NTI Ann: Q&A on NTI164 Breakthrough Clinical Trial Results in ASD - 22nd Jul 2022, 8:40am

annb0t

annb0t

Top 20
NTI Ann: Q&A on NTI164 Breakthrough Clinical Trial Results in ASD
Price Sensitive: Y
Date: 22nd Jul 2022, 8:40am

>>> Read announcement: Google: NTI Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NTI Ann: NTI Granted FDA Pre-IND Meeting for NTI164 in ASD - 19th Jan 2023, 11:30am
Replies
0
Views
136
annb0t
annb0t
annb0t
NTI Ann: BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD - 8th Jul 2022, 9:33am
Replies
0
Views
150
annb0t
annb0t
annb0t
NTI Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 27th Oct 2023, 8:08am
Replies
0
Views
56
annb0t
annb0t
annb0t
NTI Ann: Notice of Quarterly Investor Conference Call - 24th Oct 2023, 11:52am
Replies
0
Views
61
annb0t
annb0t
annb0t
NTI Ann: Notice of Annual General Meeting/Proxy Form - 16th Oct 2023, 1:25pm
Replies
0
Views
75
annb0t
annb0t
Top Bottom